Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease

David M. Good(University of Wisconsin–Madison), Petra Zürbig(Mosaiques Diagnostics and Therapeutics (Germany)), Àngel Argilés, H Bauer(Hess (United States)), Georg Behrens(Medizinische Hochschule Hannover), Joshua J. Coon(University of Wisconsin–Madison), Mohammed Dakna(Mosaiques Diagnostics and Therapeutics (Germany)), Stéphane Decramer(Inserm), Christian Delles(British Heart Foundation), Anna F. Dominiczak(British Heart Foundation), J. H. H. Ehrich(Medizinische Hochschule Hannover), Frank Eitner(RWTH Aachen University), Danilo Fliser(Saarland University), Moritz Frommberger(Helmholtz Zentrum München), Arnold Ganser(Medizinische Hochschule Hannover), Mark Girolami(University of Glasgow), Igor Golovko(Mosaiques Diagnostics and Therapeutics (Germany)), Wilfried Gwinner(Medizinische Hochschule Hannover), Marion Haubitz(Medizinische Hochschule Hannover), Stefan Herget‐Rosenthal(Krankenhaus vom Roten Kreuz), Joachim Jankowski(Charité - Universitätsmedizin Berlin), Holger Jahn(Universität Hamburg), George Jerums(The University of Melbourne), Bruce A. Julian(University of Alabama at Birmingham), Markus Kellmann(Thermo Fisher Scientific (Germany)), Volker Kliem(Medizinische Hochschule Hannover), Walter Kölch(University College Dublin), Andrzej S. Królewski(Joslin Diabetes Center), Mario Luppi(University of Modena and Reggio Emilia), Ziad A. Massy(Inserm), Michael Melter(University Hospital Regensburg), Christian Neusüß(Hochschule Aalen), Jan Novák(University of Alabama at Birmingham), Karlheinz Peter(Steno Diabetes Centers), Kasper Rossing(Steno Diabetes Centers), Harald Rupprecht(Leipzig University of Applied Sciences), Joost P. Schanstra(Inserm), Eric Schiffer(Joslin Diabetes Center), Jens‐Uwe Stolzenburg(Leipzig University), Lise Tarnow(Steno Diabetes Centers), Dan Theodorescu(University of Virginia), Visith Thongboonkerd(Siriraj Hospital), Raymond Vanholder(Ghent University Hospital), Eva M. Weissinger(Medizinische Hochschule Hannover), Harald Mischak(British Heart Foundation), Philippe Schmitt‐Kopplin(Siriraj Hospital)
Molecular & Cellular Proteomics
July 8, 2010
Cited by 537Open Access
Full Text

Abstract

Because of its availability, ease of collection, and correlation with physiology and pathology, urine is an attractive source for clinical proteomics/peptidomics. However, the lack of comparable data sets from large cohorts has greatly hindered the development of clinical proteomics. Here, we report the establishment of a reproducible, high resolution method for peptidome analysis of naturally occurring human urinary peptides and proteins, ranging from 800 to 17,000 Da, using samples from 3,600 individuals analyzed by capillary electrophoresis coupled to MS. All processed data were deposited in an Structured Query Language (SQL) database. This database currently contains 5,010 relevant unique urinary peptides that serve as a pool of potential classifiers for diagnosis and monitoring of various diseases. As an example, by using this source of information, we were able to define urinary peptide biomarkers for chronic kidney diseases, allowing diagnosis of these diseases with high accuracy. Application of the chronic kidney disease-specific biomarker set to an independent test cohort in the subsequent replication phase resulted in 85.5% sensitivity and 100% specificity. These results indicate the potential usefulness of capillary electrophoresis coupled to MS for clinical applications in the analysis of naturally occurring urinary peptides.


Related Papers

No related papers found

Powered by citation graph analysis